BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru

Reuters

Sep 26

Sept 26 (Reuters) - Onconetix Inc ONCO.O:

ONCONETIX ANNOUNCES FINANCING THROUGH A $12.9 MILLION PRIVATE PLACEMENT OF SERIES D PREFERRED STOCK AND WARRANTS, TERMINATION OF MERGER AGREEMENT WITH OCUVEX, INC. AND SETTLEMENT OF $8.8 MILLION DEBT WITH VERU, INC.

Source text: ID:nGNX62tq6f

Further company coverage: ONCO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2570166885"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570166885\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570166885?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-26 20:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570166885","market":"nz","top_or_hot":-1,"title":"BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru</title></head><body><p><span>Sept 26 (Reuters)</span><span> - </span>Onconetix Inc <span>ONCO.O</span>:</p><ul><li><p>ONCONETIX ANNOUNCES FINANCING THROUGH A $12.9 MILLION PRIVATE PLACEMENT OF SERIES D PREFERRED STOCK AND WARRANTS, TERMINATION OF MERGER AGREEMENT WITH OCUVEX, INC. AND SETTLEMENT OF $8.8 MILLION DEBT WITH VERU, INC.</p></li></ul><p>Source text: <span>ID:nGNX62tq6f</span></p><p>Further company coverage: <span>ONCO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-26 20:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With Veru</title></head><body><p><span>Sept 26 (Reuters)</span><span> - </span>Onconetix Inc <span>ONCO.O</span>:</p><ul><li><p>ONCONETIX ANNOUNCES FINANCING THROUGH A $12.9 MILLION PRIVATE PLACEMENT OF SERIES D PREFERRED STOCK AND WARRANTS, TERMINATION OF MERGER AGREEMENT WITH OCUVEX, INC. AND SETTLEMENT OF $8.8 MILLION DEBT WITH VERU, INC.</p></li></ul><p>Source text: <span>ID:nGNX62tq6f</span></p><p>Further company coverage: <span>ONCO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONCO","symbol_name":"Onconetix Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nTUA6YGW3Y:1","article_id":"2570166885","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570166885","pubTimestamp":1758890400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With VeruSept 26 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONCO":"Onconetix Inc.","BK4139":"生物科技"},"translate_title":"简介-Onconetix宣布通过私募1290万美元D轮股票和认股权证进行融资，并与Veru解决880万美元债务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONCO":0.9},"content_text":"BRIEF-Onconetix Announces Financing Through $12.9 Million Private Placement Of Series D Stock And Warrants, Settlement Of $8.8 Million Debt With VeruSept 26 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX ANNOUNCES FINANCING THROUGH A $12.9 MILLION PRIVATE PLACEMENT OF SERIES D PREFERRED STOCK AND WARRANTS, TERMINATION OF MERGER AGREEMENT WITH OCUVEX, INC. AND SETTLEMENT OF $8.8 MILLION DEBT WITH VERU, INC.Source text: ID:nGNX62tq6fFurther company coverage: ONCO.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}